St. Luke's Clinical Hospital
Saint Petersburg, Outside U.S./Canada, Russia
Location status: Recruiting
NCT Number: NCT07275879
Double-J (DJ) stents are commonly inserted after ureteroscopy. There are several complications associated with the presence of DJ stent: urinary tract infection, stent encrustation, stent migration, and stent-related symptoms (SRS).
SRS occur in up to 80% of patients and include pain, hematuria, and dysuria, all of which negatively impact the patient's quality of life.
Physicians proposed the distal end of the ureteral stents might involve in SRS by over-simulating the trigone of bladder. The design of the distal end, made with a thinner loop than that of a standard DJ stent, is intended to mitigate SRS and reduce urine reflux.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Saint Petersburg, Outside U.S./Canada, Russia
Location status: Recruiting
Study Design:
Prospective, randomized, open-label, controlled trial with two parallel arms.
Study Center:
Department of Urology, St. Luke's Clinical Hospital, St. Petersburg, Russia
Study Population:
All patients should not be prestented and should have no ureteral obstruction. 40 patients, divided into four equal groups of 20 people each:
Group I (standard DJ stent):
Group II (modified DJ stent)
Procedure for evaluation:
After surgery ( RIRS, ureteroscopy) reflux is assessed (gravity-filling cystogram). After stenting, the presence of post-stent reflux is assessed.
In the postoperative period, patients complete the USSQ (1st day, 7th day and before stent removal).
Statistics method:
The results are presented as the median and interquartile range (IQR) for continuous variables, and as frequencies (n with percentage %) for categorical variables. Statistical comparisons of all primary and secondary outcome measures between different treatment groups were conducted using the Mann-Whitney U test for continuous data. Meanwhile, categorical variables were analyzed using either Pearson's chi-square (χ²) test or Fisher's exact test, where appropriate. Thenthreshold for statistical significance was established at 5%, implying that a p-value less than 0.05 (p < 0.05) was considered statistically significant for all tests performed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ureteric stent insertion is the procedure to place a thin, flexible plastic tube that is temporarily in the ureter to help urine drain. They are placed with cystoscopic and X-ray guidances in an operating room setting
Time frame: Intraoperative
Injection of raradiopaque dye using gravity- filling cystogram followed by X-ray imaging. If contrast entered or not entered the ureter and kidney, ureteral reflux was considered positive or not, respectively.
Time frame: Postoperative: 1st and 7th day, before stent removal
Ureteral stent symptom questionnaire (USSQ) a psychometrically valid measure to evaluate symptoms and impact on quality of life of ureteral stents.
USSQ contains 38 questions and 2 visual analog scales (VAS), allowing assessment of the severity of SRS and their impact on the patient's quality of life. The questions are grouped into 6 domains:
Urinary symptoms Pain General health Work performance Sexual matters Additional problems For each domain, a score index is calculated as the sum of the points from all questions in that domain. The scale scores range from 1 to 10, with higher values indicating more severe SRS and lower quality of life.
Time frame: Preoperative
The patient's height is measured in centimeters.
Time frame: Preoperative
The patient's weight is measured in centimeters.
Time frame: Preoperative
Body mass index (BMI) is a value derived from the mass (weight) and height of a person.
BMI = kg/m2
Time frame: Intraoperative (measured from start to end of procedure)
total operative time in minutes
Time frame: Preoperative
Type of surgery: ureteroscopy or retrograde intrarenal surgery or stenting
Contact information is provided by the study sponsor or research team.
Dmitriy Sytnik
CONTACT
Yury Mikheev
CONTACT
St. Luke's Clinical Hospital, Russia
Other
Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent. Randomized Clinical Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06815107
Tolerance, Ureteral Double-J Stent
Amiens, France
View Trial DetailsNCT07101809
Calculi, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT07620873
Anxiety Disorders, Calculi
Keelung, Taiwan
View Trial DetailsNCT07685587
Acute Kidney Injury, Female Urogenital Diseases
Tekirdağ, Turkey (Türkiye)
View Trial Details